tiprankstipranks
Trending News
More News >
Syros Pharmaceuticals (SYRS)
OTHER OTC:SYRS
US Market

Syros Pharmaceuticals (SYRS) Balance Sheet

Compare
1,072 Followers

Syros Pharmaceuticals Balance Sheet

Syros Pharmaceuticals's total assets for Q3 2024 were $85.00M, a decrease of -20.36% from the previous quarter. SYRS total liabilities were $96.12M for the fiscal quarter, a -15.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 168.17M$ 244.49M$ 182.94M$ 213.25M$ 149.98M
Total Liabilities
$ 151.51M$ 116.75M$ 97.72M$ 122.70M$ 70.79M
Total Equity Gross Minority
$ 16.66M$ 127.74M$ 85.22M$ 90.55M$ 79.18M
Other Metrics
Currency in USD

Syros Pharmaceuticals Debt to Assets